Description

Description

Inosita 100mg is a prescription tablet manufactured by PharmEvo, formulated with Sitagliptin as its active ingredient. It belongs to a class of oral anti-diabetic medicines known as DPP-4 inhibitors, which support the body’s natural ability to regulate blood sugar rather than directly forcing insulin release. This strength is generally the standard full dose used for adults with type 2 diabetes mellitus who require more complete glycemic support than a lower-strength tablet can provide. Each pack contains 28 tablets, offering roughly a month’s supply for patients following a once-daily treatment routine as part of a broader diabetes management plan.

Ingredients

Each film-coated tablet of Inosita 100mg contains 100 milligrams of Sitagliptin, present in its phosphate monohydrate form, as the sole active pharmaceutical ingredient. The film coating makes the tablet easier to swallow and helps protect the active compound as it passes through the stomach before being absorbed into the bloodstream. Along with the active ingredient, the tablet includes standard inactive components such as fillers, binders, and coating agents, which exist purely to support the tablet’s structure and stability rather than to add any therapeutic effect of their own.

Dosage Form

Inosita 100mg is supplied as an oral, film-coated tablet meant for once-daily use. Being a solid oral dosage form, it should be swallowed whole with water and should not be crushed, chewed, or split, as altering the tablet could affect how evenly and predictably the medicine is absorbed.

Uses

Inosita 100mg is used to help manage blood glucose levels in adults with type 2 diabetes mellitus. By blocking the DPP-4 enzyme, it raises the levels of natural incretin hormones in the body, which prompt the pancreas to release insulin when blood sugar rises and reduce the release of glucagon, a hormone that pushes blood sugar upward. Because this action is glucose-dependent, the medicine tends to work mainly when it is actually needed, supporting a more balanced overall approach to blood sugar control. It is often prescribed together with a controlled diet and regular exercise, and it may also be combined with other oral anti-diabetic medicines when additional glucose control is required.

How to Use

Inosita 100mg is generally taken once daily, with or without food, exactly as directed by the prescribing doctor. Taking the tablet at the same time each day supports a consistent routine and more stable blood sugar levels over time. It should be swallowed whole with a glass of water rather than chewed or crushed. Patients should not adjust their dose or discontinue treatment on their own, since ongoing diabetes management typically depends on steady daily use combined with regular blood sugar monitoring. Doctors often recommend periodic check-ups and laboratory tests to evaluate how well the treatment is working and to make adjustments if needed.

Side Effects

Inosita is generally well tolerated at this strength, though some patients may experience side effects. Commonly reported effects include mild nausea, headache, or upper abdominal discomfort, and some individuals may notice drowsiness or mild diarrhea. Because this medicine is sometimes used together with other diabetes treatments, there is a possibility of low blood sugar (hypoglycemia) in combination therapy, so patients should watch for symptoms such as shakiness, sweating, or lightheadedness. In rare instances, more serious reactions such as pancreatitis, significant allergic responses, or joint pain have been reported, and any unusual or persistent symptoms should be reported to a doctor without delay.

Pregnancy & Breastfeeding

There is limited established safety data on the use of Sitagliptin during pregnancy or while breastfeeding. Inosita 100mg should therefore only be used in these situations if a doctor determines that the expected benefit outweighs any potential risk. Women who are pregnant, planning a pregnancy, or currently breastfeeding should discuss their diabetes care options with their healthcare provider before starting or continuing this medication.

Storage Instructions

Inosita tablets should be stored at room temperature, generally below 30°C, in a dry place away from direct sunlight, heat, and moisture. Keeping the tablets in their original packaging until use helps protect them from humidity. The medicine should always be kept out of the reach of children and pets, and any expired or unused tablets should be disposed of properly rather than kept for later use.

FAQs

Why would a doctor prescribe 100mg instead of a lower strength?
The 100mg dose is generally the standard full dose used when a patient needs complete glycemic support and their kidney function allows for it, as determined by their doctor.

Does Inosita 100mg cause low blood sugar by itself?
Used alone, the risk of hypoglycemia is relatively low because its glucose-lowering action depends on blood sugar levels, though the risk can rise when combined with certain other diabetes medicines.

Is Inosita 100mg suitable for type 1 diabetes?
No, it is intended specifically for type 2 diabetes mellitus and is not appropriate for managing type 1 diabetes.

How long before I notice improved blood sugar control?
Sitagliptin begins working on blood sugar shortly after each dose, but a clear overall improvement in glycemic control is typically evaluated over several weeks of consistent use.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.